PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Solid Tumor, Adult|Breast Cancer|Non Small Cell Lung Cancer|Head and Neck Cancer|Ovarian Cancer
Interventions: DRUG: CX-2009
Sponsor: CytomX Therapeutics